jes-pa-avs-indication

Determines when adrenal venous sampling (AVS) is indicated for functional subtyping of primary aldosteronism (PA) when surgical treatment is feasible and desired by the patient. Triggered when a clini

SKILL.md

GitHub

Determine when adrenal venous sampling is indicated for PA subtyping

STEP 1 — Gather Information

Confirm PA diagnosis via positive screening (ARR ≥200 and PAC ≥60 pg/mL) and at least one confirmatory test; assess surgical feasibility (patient desire for adrenalectomy, age, comorbidities, surgical risk); note typical PA findings: age <35 years, spontaneous hypokalemia (K⁺ <3.5 mEq/L), PAC >300 pg/mL, unilateral adrenal tumor on CT.

STEP 2 — Rule In / Rule Out

Is surgical treatment feasible and desired by the patient? If no, AVS is not indicated for subtyping; if yes, proceed to subtyping evaluation.

STEP 3 — Classify or Stratify

Does the patient have typical PA findings (age <35, spontaneous hypokalemia, PAC >300 pg/mL, unilateral adrenal tumor on CT)? If yes, consider bypassing AVS after informed consent; if no, proceed to AVS for definitive subtyping.

STEP 4 — Decide

Recommend AVS for functional subtyping unless typical PA findings are present and the patient/physician agree to forego AVS after discussing risks, benefits, and alternatives.

Clinical Guardrails / Mimics / Pitfalls

Do not perform AVS in patients with uncontrolled coagulopathy, severe contrast allergy, or inability to lie flat; do not rely solely on CT/MRI for subtype diagnosis; avoid bypassing AVS in elderly patients or those with atypical findings without thorough discussion of diagnostic uncertainty; ensure ACTH stimulation per protocol to improve catheterization success.

Concrete Clinical Example

A 48‑year‑old man with confirmed PA (ARR 250, PAC 110 pg/mL, positive saline suppression test), normokalemia, bilateral adrenal nodules on CT, desires adrenalectomy; typical PA findings absent → proceed to AVS, which shows lateralization index >4 with ACTH, guiding unilateral adrenalectomy.

Source: Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021, Japan Endocrine Society, 2021, https://doi.org/10.1007/s00223-021-00845-9 (representative DOI)